sloop-peptide The SL8 peptide is a well-characterized MHC class I epitope that plays a crucial role in T cell recognition and immune responses. Specifically, it is an octapeptide derived from the ovalbumin protein, known by its sequence SIINFEKL. This peptide is frequently studied in the context of cellular immunity, particularly in relation to CD8+ T cells, and is often used as a model antigen in immunological research. Understanding the SL8 peptide is essential for comprehending how the immune system presents antigens and mounts responses against them, especially in areas like vaccine development and cancer immunology.
The SL8 peptide, or SIINFEKL, is a key player in the field of immunology due to its defined structure and predictable interaction with specific immune receptorsmouse model encoding SL8 peptidein the inhon 2 of p-globin gene. Transgenic mice were identified using the PCR analysis of DNA and separation of PCR .... It is commonly presented by the Murine H-2Kb major histocompatibility complex (MHC) class I moleculeOVA alone, a complex of them orSL8for 2 h at 37°C, then fixed, washed, and cultured overnight with B32. The B-galactosidase activity was mea-.. This presentation is critical for activating CD8+ cytotoxic T lymphocytes (CTLs), which are vital for identifying and eliminating infected or cancerous cells.作者：EM Sroka·2023·被引用次数：6—The intron-derived MHC-I antigenic peptide (SL8)is expressed and recognized by specific CD8+T cells in vivo. (A) A map of the HBB knock-in mice ... Researchers frequently utilize the SL8 peptide in experiments to:
* Study antigen presentation pathways: The process by which endogenous peptides, like SL8, are processed and displayed on the cell surface via MHC class I molecules is complexas the SL8 octapeptide, and MSL8 was available to MHC,only the SL8 peptide was found in Kb cell extracts. The presence of naturally processed SL8, but not .... Studies involving SL8 help elucidate the various proteolytic and transport mechanisms involved.
* Investigate T cell activation and recognition: By exposing T cells to the SL8 peptide in conjunction with MHC class I molecules, scientists can observe and measure T cell responses, providing insights into T cell receptor (TCR) specificity and signaling.
* Develop and test immunotherapies and vaccines: The SL8 peptide serves as a benchmark antigen for evaluating the efficacy of experimental vaccines and immunotherapies designed to elicit or enhance CD8+ T cell responsesTranslation of bi-directional transcripts enhances MHC-I .... For instance, nanovaccines engineered to present the SL8 peptide have shown robust cellular immune responsesOVA peptide - MedchemExpress.com.
The SL8 peptide can originate from various sources, including naturally expressed proteins or experimentally introduced genetic constructsPresentation without Proteolytic Cleavage of Endogenous .... In experimental settings, it has been observed that the SL8 peptide sequence can be expressed from different genetic contexts, such as within introns of genes like the beta-globin gene or from bi-directional transcripts.Discrete Proteolytic Intermediates in the MHC Class I ... This highlights the adaptability of the immune system to recognize antigens derived from both coding and non-coding regions of the genome, or even from aberrant gene expression.
The presentation of the SL8 peptide on the cell surface is a tightly regulated process. It involves the endogenous processing of proteins into smaller peptides, which are then transported into the endoplasmic reticulum and loaded onto MHC class I molecules. These peptide-MHC complexes are subsequently transported to the cell surface, where they are recognized by CD8+ T cells. The precise sequence and integrity of the SL8 peptide are crucial for effective binding to the MHC molecule and subsequent T cell activation. Studies have shown that even minor modifications or the presence of additional residues can affect its presentation and recognition.Sroka E1,4, Prado Martins R2, Daskalogianni C2, ...
Research involving the SL8 peptide has significant implications for understanding fundamental immunological processes and developing novel therapeutic strategies. Its role as a model antigen has facilitated advancements in:
* Cancer immunotherapy: By understanding how CD8+ T cells recognize tumor-associated antigens presented by MHC class I molecules, researchers can design strategies to enhance anti-tumor immunity. The SL8 system provides a valuable model for testing these approachesEpstein Barr Virus-Encoded EBNA1 Interference with MHC ....
* Infectious disease research: The recognition of viral or bacterial peptides by CD8+ T cells is central to controlling infections. SL8 research contributes to our broader understanding of how the immune system combats pathogens作者：EM Sroka·2023·被引用次数：6—Here, we show thatan MHC class I epitope (SL8) sequence inserted in the second intron of the β-globin gene in a C57BL/6 mouse (HBB) generates ....
* Autoimmunity and tolerance: Investigating how the immune system distinguishes between self-peptides and foreign antigens, or how tolerance is maintained, can be informed by studies on peptide presentation, including that of SL8.Fratricide of CD8+ cytotoxic T lymphocytes is dependent on ...
In conclusion, the SL8 peptide, or SIINFEKL, is a pivotal molecule in immunology. Its well-defined nature as an MHC class I epitope, its derivation from ovalbumin, and its critical role in CD8+ T cell recognition make it an indispensable tool for unraveling the complexities of adaptive immunity and for driving innovation in vaccine and immunotherapy development.Presentation of Out-of-Frame Peptide/MHC Class I ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.